Living with prion disease is incredibly difficult because the condition involves proteins that misfold and spread in the brain. For a long time, doctors relied on repurposing old drugs to manage symptoms. Now, the focus is shifting toward more specific treatments that target the actual mechanics of the disease.
Researchers are looking at ways to stop the protein from multiplying, such as using siRNA or antisense oligonucleotides. They are also exploring immunotherapy to target the proteins directly. These methods aim to stop the disease at its source rather than just treating the symptoms. Another important area of focus is calming down the brain's inflammatory response, which can cause significant tissue damage.
While these new strategies are promising, it is important to note that human clinical evidence is still very limited and mostly in early stages. Because the disease is hard to diagnose early and the proteins are difficult to target, many of these treatments are still being tested. These findings suggest a move toward combined treatments that stop protein spread while protecting the brain from inflammation.
